Sign in
4

Changes in Ownership

NEOGENOMICS INC Filed Acc 0001077183-21-000111

Chief Executive Officer acquired 55,736 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Mallon Mark · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2021-04-19 Grant or award : show line 1 in the form +55,736 55,736 D

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-04-19 Grant or award : show line 2 in the form Stock Option (Right to Buy) +151,016 $49.34 2028-04-19 151,016 151,016 D
Loading xslF345X03/wf-form4_161904358115470.xml…